Danielle Poole, APRN
Family · Abbeville, LANPI 1811435688
Payments from drug & device makers
Across 302 payments — averaging $15.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$521
- Boehringer Ingelheim$437
- Novo Nordisk$403
- Abbott$253
- Sanofi-aventis U.S. LLC$219
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,683100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 80 | $1,194 |
| Lilly USA, LLC | 37 | $521 |
| Boehringer Ingelheim | 27 | $437 |
| Novo Nordisk | 27 | $403 |
| Abbott | 14 | $253 |
| Sanofi-aventis U.S. LLC | 13 | $219 |
| Merck | 9 | $178 |
| AstraZeneca | 11 | $149 |
| Esperion Therapeutics, Inc. | 9 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $145 |
| Johnson & Johnson | 8 | $130 |
| Currax Pharmaceuticals LLC | 8 | $107 |
| Corium, LLC | 6 | $100 |
| Amgen | 7 | $92 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $86 |
| Amarin Pharma, Inc. | 5 | $84 |
| Astellas Pharma US Inc | 5 | $77 |
| Kowa Pharmaceuticals America, Inc. | 4 | $58 |
| Pfizer | 3 | $51 |
| Novartis | 3 | $43 |
| Idorsia Pharmaceuticals US Inc | 2 | $41 |
| Dexcom, Inc. | 2 | $40 |
| Eisai Inc. | 2 | $34 |
| Exact Sciences | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Genentech USA, Inc. | 3 | $15 |
How this compares
$4,683 in reported general payments places this provider in the 90th percentile of 3,610 family providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Once Weekly)Estradiol | 12 | $1,092 |
| Celecoxib | 16 | $372 |
| Pantoprazole Sodium | 17 | $331 |
| Famotidine | 22 | $277 |
| Tamsulosin Hcl | 15 | $212 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $195 |
| Paroxetine Hcl | 11 | $175 |
| Rosuvastatin Calcium | 26 | $172 |
| Losartan Potassium | 30 | $164 |
| Atorvastatin Calcium | 18 | $137 |
| Meloxicam | 25 | $133 |
| Levothyroxine Sodium | 31 | $133 |
| Alprazolam | 27 | $114 |
| Memantine Hcl | 12 | $108 |
| Amlodipine Besylate | 12 | $105 |
Paid to pharmacies, not to this prescriber.
Other family in Abbeville
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.